VigiPallia : Résultats

DYSPNEE

0 sélectionnée(s) / 261 réponse(s)

(1) 2 3 4 ... 14 > »

Acupuncture for breathlessness in advanced diseases - a systematic review and meta-analysis

VON TROTT, Philipp ; OEI, Shiao Li ; RAMSENTHALER, Christina
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 02/2020, vol.59, n°2, p. 327-338

Document en ligne

Opioid underuse in terminal care of long-term care facility residents with pain and/or dyspnoea - a cross-sectional pace-survey in six European countries

TANGHE, Marc ; VAN DEN NOORTGATE, Nele ; DELIENS, Luc ; SMETS, Tinne ; ONWUTEAKA-PHILIPSEN, Bregje ; SZCZERBINSKA, Katarzyna ; FINNE-SOVERI, Harriet ; PAYNE, Sheila ; GAMBASSI, Giovanni ; VAN DEN BLOCK, Lieve ; PIERS, Ruth
PALLIATIVE MEDICINE, 14/04/2020, Pagination inconnue

Document en ligne

Place des opiacés dans le traitement de la dyspnée en soins palliatifs

KALLEL, Nesrine ; YANGUI, Ilhem ; FEKI, Walid ; AYEDI, Hajeur ; KAMMOUN, Samy
MEDECINE PALLIATIVE, Elsevier, 04/2020, vol.19, n°2, p. 114-120

Document en ligne

Immediate effect of fan therapy in terminal cancer with dyspnea at rest - a meta-analysis

KAKO, Jun ; KOBAYASHI, Masamitsu ; OOSONO, Yasufumi ; KAJIWARA, Kohei ; MIYASHITA, Mika
The American journal of hospice and palliative care, 04/2020, vol.37, n°4, p. 294-299

Document en ligne

Association between heart rate and reversibility of the symptom, refractoriness to palliative treatment, and survival in dyspneic cancer patients

MORI, Ichiro ; MAEDA, Isseki ; MORITA, Tatsuya ; INOUE, Satoshi ; IKENAGA, Masayuki ; SEKINE, Ryuichi ; YAMAGUCHI, Takashi ; HIROHASHI, Takeshi ; TAJIMA, Tsukasa ; WATANABE, Hiroaki
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 20/02/2020, Pagination inconnue

Document en ligne

Oxygen use and survival in patients with advanced cancer and low oxygen saturation in home care - a preliminary retrospective cohort study

IGARASHI, Hiroshi ; FUKUSHI, Motoharu ; NAGO, Naoki
BMC palliative care, 03/01/2020, vol.19, n°1, p. 1-10

Document en ligne

Opioid utility for dyspnea in chronic obstructive pulmonary disease - a complicated and controversial story

VOZORIS, Nicholas T.
Annals of palliative medicine, 15/12/2019, Pagination inconnue

Document en ligne

Benzodiazepines for cancer dyspnoea - a nationwide survey of palliative care physicians

MATSUDA, Yoshinobu ; MATSUNUMA, Ryo ; SUZUKI, Kozue ; MORI, Masanori ; WATANABE, Hiroaki ; YAMAGUCHI, Takashi
BMJ supportive and palliative care, 09/12/2019, Pagination inconnue

Document en ligne

Management of chronic dyspnea #376

WEINBERG, Richard ; KETTERER, Briana
JOURNAL OF PALLIATIVE MEDICINE, 01/07/2019, vol.22, n°7, p. 858-860

Document en ligne

High-flow nasal cannula versus conventional oxygen therapy in relieving dyspnea in emergency palliative patients with do-not-intubate status - a randomized crossover study

RUANGSOMBOON, Onlak ; DORONGTHOM, Thawonrat ; CHAKORN, Tipa ; MONSOMBOON, Apichaya ; PRAPHRUETKIT, Nattakarn ; LIMSUWAT, Chok ; SURABENJAWONG, Usapan ; RIYAPAN, Sattha ; NAKORNCHAI, Tanyaporn ; CHAISIRIN, Wansiri
Annals of emergency medicine, 18/12/2019, p. 1-12

Document en ligne

Fan therapy for the relief of dyspnea in adults with advanced disease and terminal illness - a meta-analysis of randomized controlled trials

YU, Shui ; SUN, Kai ; XING, Xiufang ; ZHONG, Yinbo ; YAN, Xuemei ; QIU, Weidong ; YAN, Min
JOURNAL OF PALLIATIVE MEDICINE, 12/2019, vol.22, n°12, p. 1603-1609

Document en ligne

Polypharmacy increases risk of dyspnea among adults with serious, life-limiting diseases

AKGUN, Kathleen M. ; KRISHNAN, Supriya ; FEDER, Shelli L. ; TATE, Janet ; KUTNER, Jean S. ; CROTHERS, Kristina
The American journal of hospice and palliative care, 24/09/2019, Pagination inconnue

Document en ligne

Thème : Médicaments - Pharmacie.

THERAPEUTIQUE MEDICAMENTEUSE ; DYSPNEE ; MALADIE LETALE

Background: Polypharmacy is associated with dyspnea in cross-sectional studies, but associations have not been determined in longitudinal analyses. Statins are commonly prescribed but their contribution to dyspnea is unknown. We determined whether polypharmacy was associated with dyspnea trajectory over time in adults with advanced illness enrolled in a statin discontinuation trial, overall, and in models stratified by statin discontinuation.
Methods: Using data from a parallel-group unblinded pragmatic clinical trial (patients on statins =3 months with life expectancy of 1 month to 1 year, enrolled in the parent study between June 3, 2011, and May 2, 2013, n = 308/381 [81%]), we restricted analyses to patients with available baseline medication count and =1 dyspnea score. Polypharmacy was assessed by self-reported chronic medication count. Dyspnea trajectory group, our primary outcome, was determined over 24 weeks using the Edmonton Symptom Assessment System.
Results: The mean age of the patients was 73.8 years (standard deviation [SD]: ±11.0) and the mean medication count was 11.6 (SD: ±5.0). We identified 3 dyspnea trajectory groups: none (n = 108), mild (n = 130), and moderate–severe (n = 70). Statins were discontinued in 51.8%, 48.5%, and 42.9% of patients, respectively. In multivariable models adjusting for age, sex, diagnosis, and statin discontinuation, each additional medication was associated with 8% (odds ratio [OR] = 1.08 [1.01-1.14]) and 16% (OR = 1.16 [1.08-1.25]) increased risk for mild and moderate–severe dyspnea, respectively. In stratified models, polypharmacy was associated with dyspnea in the statin continuation group only (mild OR = 1.12 [1.01-1.24], moderate–severe OR = 1.24 [1.11-1.39]) versus statin discontinuation (mild OR = 1.03 [0.95-1.12], and moderate–severe OR = 1.09 [0.98-1.22]).
Conclusion: Polypharmacy was strongly associated with dyspnea. Prospective interventions to decrease polypharmacy may impact dyspnea symptoms, especially for statins.

Origine : PubMed

Symptomatic treatment of dyspnea in advanced cancer patients - a narrative review of the current literature

STRIEDER, Matthaus ; PECHERSTORFER, Martin ; KREYE, Gudrun
Wiener medizinische wochenschrift, 10/2018, vol.168, n°13-14, p. 333-343

Document en ligne

The current practice of opioid for cancer dyspnea - the result from the nationwide survey of japanese palliative care physicians

YAMAGUCHI, Takashi ; MATSUNUMA, Ryo ; SUZUKI, Kozue ; MATSUDA, Yoshinobu ; MORI, Masanori ; WATANABE, Hiroaki
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 12/06/2019, Pagination inconnue

Document en ligne

Autonomy and dyspnea in palliative care - a case report

MARTINS, M. ; CAMPOA, E. ; FERREIRA, M. ; REIS-PINA, P.
Pulmonology, 31/05/2019, p. 1-3

Document en ligne

Effect of palliative bronchoscopic interventions on symptom burden in patients with central airway narrowing - a retrospective review

PANDIT, Anuja ; GUPTA, Nishkarsh ; KUMAR, Vinod ; BHARATI, Sachidanand Jee ; GARG, Rakesh ; MADAN, Karan ; MISHRA, Seema ; BHATNAGAR, Sushma
Indian journal of palliative care, 06/2019, vol.25, n°2, p. 250-253

Document en ligne

Palliative care in chronic obstructive pulmonary disease

SORATHIA, Lubna
The Medical Clinics of North America, 05/2019, vol.103, n°3, p. 517-526

Document en ligne

From tramadol to methadone - opioids in the treatment of pain and dyspnea in pediatric palliative care

FRIEDRICHSDORF, Stefan J.
The clinical journal of pain, 06/2019, vol.35, n°6, p. 501-508

Document en ligne

Opioids for relief of dyspnea immediately before death in patients with noncancer disease - a case series study

MURAKAMI, Maki
The American journal of hospice and palliative care, 08/2019, vol.36, n°8, p. 734-739

Document en ligne

(1) 2 3 4 ... 14 > »

Actions

##titre_notice##